Arseus realises successful IPO at EUR 10.25 per share
The Offering was approximately 2 times oversubscribed
Arseus NV has successfully completed its initial public offering (IPO). The Offering was approximately 2 times oversubscribed at an Offer Price of EUR 10.25 per share. The Shares, VVPR strips and Offering Warrants will be listed as of tomorrow, October 5, on Eurolist by Euronext Brussels. The Shares will also be traded on Eurolist by Euronext Amsterdam.
Pursuant to the Offering, Omega Pharma sold 20,468,144 existing shares for a total amount of EUR 209.8 million. Additionally, 6,000,000 new shares were issued, raising a total of EUR 61.5 million in gross proceeds. An over-allotment option of 2,968,144 existing shares has been granted. The total amount of allocated shares thus amounts to 26,468,144 which, at the final IPO price of EUR 10.25, corresponds to a total amount raised of EUR 271 million.
The details with regard to the allocation of shares to retail investors will be published in the Belgian financial press on Friday, October 5, 2007 and will be announced on the websites of Arseus and Omega Pharma as well as the Belgian syndicate banks